Somatic mutations and epigenetic abnormalities in myelodysplastic syndromes

Best Practice and Research: Clinical Haematology

Volumn 26, Issue 4, 2013, Pages 355-364

  Itzykson, Raphael ^a   Kosmider, Olivier ^b,c   Fenaux, Pierre ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b Institut Cochin   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

epigenetics; genetics; histone; methylation; myelodysplastic syndromes

Indexed keywords

POLYCOMB REPRESSIVE COMPLEX 2;

DEMETHYLATION; DNA METHYLATION; EPIGENETICS; GENETIC SCREENING; HISTONE MODIFICATION; HUMAN; INTRACELLULAR SIGNALING; LOSS OF FUNCTION MUTATION; MUTATIONAL ANALYSIS; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SOMATIC MUTATION;

EPIGENETICS; GENETICS; HISTONE; METHYLATION; MYELODYSPLASTIC SYNDROMES;

DNA METHYLATION; EPIGENESIS, GENETIC; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MUTATION; MYELODYSPLASTIC SYNDROMES; PROGNOSIS; SIGNAL TRANSDUCTION;

EID: 84893721635     PISSN: 15216926     EISSN: 15321924     Source Type: Journal    
DOI: 10.1016/j.beha.2014.01.001     Document Type: Review

References (67)

1. M.E. Figueroa, L. Skrabanek, and Y. Li et al. MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation Blood 114 16 2009 Oct 15 3448 3458
2. Y. Jiang, A. Dunbar, and L.P. Gondek et al. Aberrant DNA methylation is a dominant mechanism in MDS progression to AML Blood 113 6 2009 Feb 5 1315 1325
3. Y. Wei, R. Chen, and S. Dimicoli et al. Global H3K4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of JMJD3 in human myelodysplastic syndrome CD34+ cells Leukemia 27 11 2013 Nov 2177 2186
4. M. del Rey, K. O'Hagan, and M. Dellett et al. Genome-wide profiling of methylation identifies novel targets with aberrant hypermethylation and reduced expression in low-risk myelodysplastic syndromes Leukemia 27 3 2013 Mar 610 618
5. V. Radulovic, G. de Haan, and K. Klauke Polycomb-group proteins in hematopoietic stem cell regulation and hematopoietic neoplasms Leukemia 27 3 2013 Mar 523 533
6. K. Mihara, M. Chowdhury, and N. Nakaju et al. Bmi-1 is useful as a novel molecular marker for predicting progression of myelodysplastic syndrome and patient prognosis Blood 107 1 2006 Jan 1 305 308
7. O. Abdel-Wahab, and A. Dey The ASXL-BAP1 axis: new factors in myelopoiesis, cancer and epigenetics Leukemia 27 1 2013 Jan 10 15
8. J. Boultwood, J. Perry, and A. Pellagatti et al. Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia Leukemia 24 5 2010 1062 1065
9. O. Abdel-Wahab, M. Adli, and L.M. LaFave et al. ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression Cancer Cell 22 2 2012 Aug 14 180 193
10. C. Perez, N. Martinez-Calle, and J.I. Martin-Subero et al. TET2 mutations are associated with specific 5-methylcytosine and 5-hydroxymethylcytosine profiles in patients with chronic myelomonocytic leukemia PLoS One 7 2 2012 e31605
11. J. Yamazaki, R. Taby, and A. Vasanthakumar et al. Effects of TET2 mutations on DNA methylation in chronic myelomonocytic leukemia Epigenetics 7 2 2012 Feb 201 207
12. S.J. Song, K. Ito, and U. Ala et al. The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation Cell Stem Cell 13 1 2013 Jul 3 87 101
13. F. Asmar, V. Punj, and J. Christensen et al. Genome-wide profiling identifies a DNA methylation signature that associates with TET2 mutations in diffuse large B-cell lymphoma Haematologica 98 12 2013 Dec 1912 1920
14. P. Guilhamon, M. Eskandarpour, and D. Halai et al. Meta-analysis of IDH-mutant cancers identifies EBF1 as an interaction partner for TET2 Nat Commun 17 4 2013 Jul 2166
15. M.T. Bocker, F. Tuorto, and G. Raddatz et al. Hydroxylation of 5-methylcytosine by TET2 maintains the active state of the mammalian HOXA cluster Nat Commun 3 2012 818
16. Q. Chen, Y. Chen, and C. Bian et al. TET2 promotes histone O-GlcNAcylation during gene transcription Nature 493 7433 2013 Jan 24 561 564
17. P. Ramakrishnan, P.M. Clark, and D.E. Mason et al. Activation of the transcriptional function of the NF-kappaB protein c-Rel by O-GlcNAc glycosylation Sci Signal 6 290 2013 ra75
18. A. Kon, L.Y. Shih, and M. Minamino et al. Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms Nat Genet 45 10 2013 Oct 1232 1237
19. G.W. Rhyasen, and D.T. Starczynowski Deregulation of microRNAs in myelodysplastic syndrome Leukemia 26 1 2011 Jan 13 22
20. R. Garzon, S. Liu, and M. Fabbri et al. MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1 Blood 113 25 2009 Jun 18 6411 6418
21. C. Santamaria, S. Muntion, and B. Roson et al. Impaired expression of DICER, DROSHA, SBDS and some microRNAs in mesenchymal stromal cells from myelodysplastic syndrome patients Haematologica 97 8 2012 Aug 1218 1224
22. M.H. Raaijmakers, S. Mukherjee, and S. Guo et al. Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia Nature 464 7290 2010 Apr 8 852 857
23. E. Yildirim, J.E. Kirby, and D.E. Brown et al. Xist RNA is a potent suppressor of hematologic cancer in mice Cell 152 4 2013 Feb 14 727 742
24. J.L. Rinn, M. Kertesz, and J.K. Wang et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs Cell 129 7 2007 Jun 29 1311 1323
25. W. Yu, D. Gius, and P. Onyango et al. Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA Nature 451 7175 2008 Jan 10 202 206
26. L.I. Gomez Acuna, A. Fiszbein, and M. Allo et al. Connections between chromatin signatures and splicing Wiley Interdiscip Rev RNA 4 1 2013 Jan-Feb 77 91
27. W. Timp, and A.P. Feinberg Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host Nat Rev Cancer 13 7 2013 Jul 497 510
28. S.M. Chambers, C.A. Shaw, and C. Gatza et al. Aging hematopoietic stem cells decline in function and exhibit epigenetic dysregulation PLoS Biol 5 8 2007 Aug e201
29. M.T. Bocker, I. Hellwig, and A. Breiling et al. Genome-wide promoter DNA methylation dynamics of human hematopoietic progenitor cells during differentiation and aging Blood 117 19 2011 May 12 e182 e189
30. I. Beerman, C. Bock, and B.S. Garrison et al. Proliferation-dependent alterations of the DNA methylation landscape underlie hematopoietic stem cell aging Cell Stem Cell 12 4 2013 Apr 4 413 425
31. M. Kim, H. Kook, and H.J. Park et al. Quantitative comparison of CDKN2B methylation in Pediatric and adult myelodysplastic syndromes Acta Haematol 130 2013 115 121
32. H.C. Hasselbalch Perspectives on chronic inflammation in essential thrombocythemia, polycythemia vera, and myelofibrosis: is chronic inflammation a trigger and driver of clonal evolution and development of accelerated atherosclerosis and second cancer? Blood 119 14 2012 Apr 5 3219 3225
33. Y. Ye, M.A. McDevitt, and M. Guo et al. Progressive chromatin repression and promoter methylation of CTNNA1 associated with advanced myeloid malignancies Cancer Res 69 21 2009 Nov 1 8482 8490
34. A. Aziz, E.J. Baxter, and C. Edwards et al. Cooperativity of imprinted genes inactivated by acquired chromosome 20q deletions J Clin Invest 123 5 2013 May 1 2169 2182
35. A. Venkatraman, X.C. He, and J.L. Thorvaldsen et al. Maternal imprinting at the H19-Igf2 locus maintains adult haematopoietic stem cell quiescence Nature 500 7462 2013 Aug 15 345 349
36. G.A. Challen, D. Sun, and M. Jeong et al. Dnmt3a is essential for hematopoietic stem cell differentiation Nat Genet 44 1 2012 Jan 23 31
37. A. Herrera-Merchan, L. Arranz, and J.M. Ligos et al. Ectopic expression of the histone methyltransferase Ezh2 in haematopoietic stem cells causes myeloproliferative disease Nat Commun 3 2012 623
38. C.L. Fisher, N. Pineault, and C. Brookes et al. Loss-of-function additional sex combs like 1 mutations disrupt hematopoiesis but do not cause severe myelodysplasia or leukemia Blood 115 1 2010 38 46
39. O. Abdel-Wahab, J. Gao, and M. Adli et al. Conditional deletion of Asxl1 results in myelodysplasia ASH annual meeting abstracts 2012 vol. 120(21) November 16, 2012 308
40. K. Theilgaard-Monch, J. Boultwood, and S. Ferrari et al. Gene expression profiling in MDS and AML: potential and future avenues Leukemia 25 6 2011 Jun 909 920
41. S.W. Lane, S.M. Sykes, and F. Al-Shahrour et al. The Apc(min) mouse has altered hematopoietic stem cell function and provides a model for MPD/MDS Blood 115 17 2010 Apr 29 3489 3497
42. C.X. Song, K.E. Szulwach, and Q. Dai et al. Genome-wide profiling of 5-formylcytosine reveals its roles in epigenetic priming Cell 153 3 2013 Apr 25 678 691
43. J.J. Trowbridge, A.U. Sinha, and N. Zhu et al. Haploinsufficiency of Dnmt1 impairs leukemia stem cell function through derepression of bivalent chromatin domains Genes Dev 26 4 2012 Feb 15 344 349
44. J.X. Cheng, J. Anastasi, and K. Watanabe et al. Genome-wide profiling reveals epigenetic inactivation of the PU.1 pathway by histone H3 lysine 27 trimethylation in cytogenetically normal myelodysplastic syndrome Leukemia 27 6 2013 Jun 1291 1300
45. C. Davies, B.H. Yip, and M. Fernandez-Mercado et al. Silencing of ASXL1 impairs the granulomonocytic lineage potential of human CD34(+) progenitor cells Br J Haematol 160 6 2013 Mar 842 850
46. O. Hopfer, F. Nolte, and M. Mossner et al. Epigenetic dysregulation of GATA1 is involved in myelodysplastic syndromes dyserythropoiesis Eur J Haematol 88 2 2012 Feb 144 153
47. A. Raval, K.J. Sridhar, and S. Patel et al. Reduced rRNA expression and increased rDNA promoter methylation in CD34+ cells of patients with myelodysplastic syndromes Blood 120 24 2012 Dec 6 4812 4818
48. J.J. Wong, W. Ritchie, and O.A. Ebner et al. Orchestrated intron retention regulates normal granulocyte differentiation Cell 154 3 2013 Aug 1 583 595
49. M.J. Walter, D. Shen, and L. Ding et al. Clonal architecture of secondary acute myeloid leukemia N Engl J Med 366 12 2012 Mar 22 1090 1098
50. C. Lorthongpanich, L.F. Cheow, and S. Balu et al. Single-cell DNA-methylation analysis reveals epigenetic chimerism in preimplantation embryos Science 341 6150 2013 Sep 6 1110 1112
51. E.H. Estey Epigenetics in clinical practice: the examples of azacitidine and decitabine in myelodysplasia and acute myeloid leukemia Leukemia 27 9 2013 Sep 1803 1812
52. S. Thepot, E. Lainey, and T. Cluzeau et al. Hypomethylating agents reactivate FOXO3A in acute myeloid leukemia Cell Cycle 10 14 2011 Jul 15 2323 2330
53. J.M. Klco, D.H. Spencer, and T.L. Lamprecht et al. Genomic impact of transient low-dose decitabine treatment on primary AML cells Blood 121 9 2013 Feb 28 1633 1643
54. K. Pandiyan, J.S. You, and X. Yang et al. Functional DNA demethylation is accompanied by chromatin accessibility Nucleic Acids Res 41 7 2013 Apr 3973 3985
55. C. Flotho, R. Claus, and C. Batz et al. The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute myeloid leukemia cells Leukemia 23 6 2009 Jun 1019 1028
56. V. Khoddami, and B.R. Cairns Identification of direct targets and modified bases of RNA cytosine methyltransferases Nat Biotechnol 31 5 2013 May 458 464
57. A. Kon, L.Y. Shih, and M. Minamino et al. Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms Nat Genet 45 10 2013 Oct 1232 1237
58. H. Makishima, K. Yoshida, and N. Nguyen et al. Somatic SETBP1 mutations in myeloid malignancies Nat Genet 45 8 2013 Aug 942 946
59. F. Thol, K.J. Suchanek, and C. Koenecke et al. SETBP1 mutation analysis in 944 patients with MDS and AML Leukemia 27 10 2013 Oct 2072 2075
60. F. Damm, R. Itzykson, and O. Kosmider et al. SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias Leukemia 27 6 2013 Jun 1401 1403
61. I. Gómez-Seguí, H. Makishima, and A. Jerez et al. Novel recurrent mutations in the RAS-like GTP-binding gene RIT1 in myeloid malignancies Leukemia 27 9 2013 Sep 1943 1946
62. F. Damm, V. Chesnais, and Y. Nagata et al. BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders Blood 122 18 2013 Oct 31 3169 3177
63. E. Papaemmanuil, M. Gerstung, and L. Malcovati et al. Clinical and biological implications of driver mutations in myelodysplastic syndromes Blood 122 22 2013 Nov 21 3616 3627
64. Haferlach T, Nagata Y, Grossmann V, et al. Landscape of genetic lesions in 944 patients with myelodysplastic syndromes. 10.1038/leu.2013.336.
65. M.J. Walter, D. Shen, and J. Shao et al. Clonal diversity of recurrently mutated genes in myelodysplastic syndromes Leukemia 27 6 2013 Jun 1275 1282
66. D.M. Murphy, R. Bejar, and K. Stevenson et al. NRAS mutations with low allele burden have independent prognostic significance for patients with lower risk myelodysplastic syndromes Leukemia 27 10 2013 Oct 2077 2081
67. A.M. Mohamedali, H. Alkhatabi, and A. Kulasekararaj et al. Utility of peripheral blood for cytogenetic and mutation analysis in myelodysplastic syndrome Blood 122 4 2013 Jul 25 567 570